Sort
17,288 grants matching “multiple sclerosis”
Contribution of antibodies targeting PLP1-anchored membrane domains to multiple sclerosis pathogenesis
$406,815Jeffrey L Bennett · University Of Colorado Denver · R01 · FY2025 · NS
Binding and Presentation of Lipid Antigens by CD1
$406,742Steven A Porcelli · Albert Einstein College Of Medicine · R01 · FY2012 · AI
Binding and Presentation of Lipid Antigens by CD1
$406,742Steven A Porcelli · Albert Einstein College Of Medicine · R01 · FY2011 · AI
Neural Stem Cells and Regulatory T Cells
$406,654Samia J. Khoury · Brigham And Women'S Hospital · R56 · FY2012 · AI
Robust 3D MR spectroscopic imaging through multi-coil magnetic field shaping
$406,504Robin A De Graaf · Yale University · R01 · FY2020 · EB
More than a Movement Disorder: Applying Palliative Care to Parkinson's Disease
$406,379Benzi M Kluger · University Of Colorado Denver · R01 · FY2018 · NR
Nanowell-based single-cell technology for characterizing clinical samples ex vivo
$406,318John Christopher Love · Massachusetts Institute Of Technology · R56 · FY2012 · AI
Oral IFN-tau treatment in RRMS patients
$406,236Pepgen Corporation · R43 · FY2004 · AI
Development of Immunological Reagents for the Identification of New World Monkey Biomarkers
$406,228Luis David Giavedoni · Trinity University · R24 · FY2024 · OD
Role of Ataxin-2 polyglutamine expansion on TDP-43 transport and post-transcriptional RNA regulation in neurons
$405,978Pallavi P. Gopal · Yale University · R01 · FY2024 · NS
A Single Dose Pharmaco-Diagnostic for Peripheral Nerve Continuity After Trauma
$405,900John Elfar · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2021 · NS
Intranasal Stem-Cell Based Therapy for Glioblastoma
$405,762Maciej S Lesniak · Northwestern University At Chicago · R01 · FY2017 · NS
NEUROLOGICAL PARANEOPLASTIC SYNDROMES
$405,750Sloan-Kettering Institute For Cancer Res · R01 · FY2004 · NS
Translational studies of human viruses and chronic neurologic disease
$405,720Steven Jacobson · National Institute Of Neurological Disorders And Stroke · ZIA · FY2024 · NS
Upper-respiratory infection, oligodendrocyte plasticity and behavior
$405,672Andrew Jonathan Steelman · University Of Illinois At Urbana-Champaign · R21 · FY2021 · NS
Short Stabilized EPO-Peptide as Therapeutic Agents for Multiple Sclerosis and Acute Brain Trauma
$405,552Asaf Alimardanov · National Center For Advancing Translational Sciences · ZIA · FY2017 · TR
ANTISENSE INHIBITORS FOR TREATMENT OF MULTIPLE SCLEROSIS
$405,510Salus Therapeutics · R44 · FY2001 · NS
Mechanisms of Neurotrophin and Ephrin Signal Integration
$405,357Moses Victor Chao · Univ Of Med/Dent Nj-R W Johnson Med Sch · P01 · FY2009 · HD
Immunotherapeutic Targeting CD74 as a Treatment for Stimulant Use Disorder
$405,334Renee Lynn Shirley · Virogenomics Biodevelopment, Inc. · R41 · FY2024 · DA
Contribution of antibodies targeting PLP1-anchored membrane domains to multiple sclerosis pathogenesis
$405,282Jeffrey L Bennett · University Of Colorado Denver · R01 · FY2024 · NS
Investigating the role of CD44 and immune-neuro signaling mechanisms in neural stem cell responses after spinal cord injury
$405,171Aileen J Anderson · University Of California-Irvine · R01 · FY2024 · NS
Tuberous Sclerosis-Pathway and Pathogenesis
$405,156David J. Kwiatkowski · Brigham And Women'S Hospital · P01 · FY2007 · CA
Subjective Valuation of Physical Effort in Health and Disease
$405,076Vikram S Chib · Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2020 · HD
Drug-mediated enhancement of myelination
$405,069Paul Joseph Tesar · Case Western Reserve University · R01 · FY2015 · NS
Subjective Valuation of Physical Effort in Health and Disease
$405,062Vikram S Chib · Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2019 · HD